Brief: PolyPeptide Group FY EBITDA EUR -5.999 Million
12/03/2024 06:08
Mar 12 (Reuters) - PolyPeptide Group FY capex EUR 54.89 million. * FY EBITDA EUR -5.999 million * FY EBIT EUR -36.468 million * FY revenue EUR 320.372 million vs. IBES estimate EUR 293 million * FY cash flow from operating activities EUR 36.485 million
Recent news on PolyPeptide AG
See all newsEurope Research Roundup: Assa Abloy, DHL, Randstad
Brief: Polypeptide Is Said To Shortlist EQT, IDG For Next Bidding Round - Bloomberg News
Brief: Polypeptide Group Says It Is Conducting Review Of Strategic Options
PolyPeptide attracts takeover interest from EQT, KKR, Bloomberg News reports
Media: PolyPeptide Is Said to Attract Takeover Interest From EQT, KKR - Bloomberg News